Grow
Flo Rida’s JettSet1 Enterprises and Biom Therapeutics Partner To Bring the First Cannabinoid-Derived, FDA Approved Orphan Status Therapeutic Agent To Treat ‘Angelman Syndrome’
https://mgmagazine.com/press-releases/flo-ridas-jettset1-enterprises-and-biom-therapeutics-partner-to-bring-the-first-cannabinoid-derived-fda-approved-orphan-status-therapeutic-agent-to-treat-angelman-syndrome/